|
Bharatbook.com announces a new report on "Global Dermatophytic Onychomycosis Therapeutics Market" the Global Dermatophytic Onychomycosis Therapeutics market to grow at a CAGR of 7.28 percent over the period 2012-2016. Oct 2, 2013 : The Global Dermatophytic Onychomycosis Therapeutics market to grow at a CAGR of 7.28 percent over the period 2012-2016. One of the key factors contributing to this market growth is the strong and promising pipeline. The Global Dermatophytic Onychomycosis Therapeutics market has also been witnessing an increased focus on combination therapies for the treatment of dermatophytic onychomycosis. However, the adverse side effects associated with drugs could pose a challenge to the growth of this market. Global Dermatophytic Onychomycosis Therapeutics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Dermatophytic Onychomycosis Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this market space are Anacor Pharmaceuticals Inc., Celtic Pharmaceutical Holdings L.P., Genelabs Technologies Inc., Hisamitsu Pharmaceutical Co. Inc., Janssen Biotech Inc., Mayne Pharma Ltd., Merck & Co. Inc., NanoBio Corp., Novartis International AG, Palau Pharma S.A., Pfizer Inc., Promius Pharma LLC , Stiefel laboratories Inc., Topica Pharmaceuticals Inc., Valeant Pharmaceuticals International Key questions answered in this report: What will the market size be in 2016 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of these key vendors? 01. Executive Summary 02. Scope of the Report 02.1 Market Overview 02.2 Product Offerings 03. Market Research Methodology 03.1 Market Research Process 03.2 Research Design 03.3 Research Methodology 04. List of Abbreviations 05. Introduction 06. Types of Dermatophytic Onychomycosis 06.1.1 Distal Subungual Onychomycosis 06.1.2 Proximal Subungual Onychomycosis 06.1.3 White Superficial Onychomycosis 06.1.4 Candidal Onychomycosis 07. Currently Approved Drugs 07.1 Oral Agents 07.1.1 Terbinafine 07.1.2 Itraconazole 07.1.3 Griseofulvin 07.1.4 Fluconazole 07.2 Topical Agents 07.2.1 Ciclopirox 07.2.2 Amorolfine 07.2.3 Ketoconazole 08. Market Landscape 08.1 Market Overview 08.2 Market Size and Forecast 08.3 Dermatophytic Onychomycosis Market in the US 08.3.1 Market Segmentation 08.3.2 Itraconazole Sales in the US 08.3.3 Flucanozole Sales in the US 08.3.4 Griseofulvin Sales in the US 08.3.5 Ketoconazole Sales in the US 08.4 Five Forces Analysis 09. Geographical Segmentation 09.1 Global Dermatophytic Onychomycosis Therapeutics Market by Geographical Segmentation 2012-2016 10. Rate of Incidence and Prevalence 11. Pipeline Analysis 12. Buying Criteria 13. Market Growth Drivers 14. Drivers and their Impact 15. Market Challenges 16. Impact of Drivers and Challenges 17. Market Trends 18. Trends and their Impact 19. Vendor Landscape 19.1 Competitive Scenario 19.1.1 Key News 19.1.2 Mergers and Acquisitions 19.2 Other Prominent Vendors 20. Key Vendor Analysis 20.1 Anacor Pharmaceuticals Inc. 20.1.1 Business Overview 20.1.2 Key Information 20.1.3 SWOT Analysis 20.2 Janssen Biotech Inc. 20.2.1 Business Overview 20.2.2 Key Information 20.2.3 SWOT Analysis 20.3 Novartis International AG 20.3.1 Business Overview 20.3.2 Business Segmentation 20.3.3 Key Information 20.3.4 SWOT Analysis 20.4 Pfizer Inc. 20.4.1 Business Overview 20.4.2 Business Segmentation 20.4.3 Key Information 20.4.4 SWOT Analysis 21. Other Reports in this Series List of Exhibits Exhibit 1: Market Research Methodology Exhibit 2: Nail Unit Dorsal and Lateral View Exhibit 3: Types of Dermatophytic Onychomycosis Exhibit 4: Global Dermatophytic Onychomycosis Therapeutics Market Overview Exhibit 5: Global Dermatophytic Onychomycosis Therapeutics Market 2012-2016 (US$ billion) Exhibit 6: Dermatophytic Onychomycosis Therapeutics Market in the US 2012-2016 (US$ million) Exhibit 7: Dermatophytic Onychomycosis Market in the US Segmentation Exhibit 8: Itraconazole Sales in the US 2012-2016 (US$ million) Exhibit 9: Fluconazole Sales in the US 2012-2016 (US$ million) Exhibit 10: Griseofulvin Sales in the US 2012-2016 (US$ million) Exhibit 11: Ketoconazole Sales in the US 2012-2016 (US$ million) Exhibit 12: Global Dermatophytic Onychomycosis Therapeutics Market by Geographical Segmentation 2012 Exhibit 13: Business Segmentation of Novartis International AG Exhibit 14: Business Segmentation of Pfizer Inc. For more information kindly visit : http://www.bharatbook.com/healthcare-market-research-reports/global-dermatophytic-onychomycosis-therapeutics-market-2012-2016.html Related link : http://www.bharatbook.com/market-research-report/healthcare.html About Bharat Book Bureau: Bharat Book Bureau is the leading market research information provider for market research reports, , company profiles, industry analysis , country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology. In case the reports don’t match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself. Contact us at : Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Toll Free No for USA/Canada : 1-866-279-8368 Call UK +44 7405 208461 Email: info@bharatbook.com Website: www.bharatbook.com Follow us on twitter: https://twitter.com/researchbook Follow us on linked in : http://www.linkedin.com/company/bharat-book-bureau Our Blog : http://blog.bharatbook.com/
Related Articles -
healthcare market, dermatophytic onychomycosis therapeutics market, market research report.,
| 
